抗衰老酶蛋白SIRT6与炎症反应在慢性疾病中研究进展

doi:10.3969/j.issn.1005-4979.2019.04.010

《口腔颌面外科杂志》

• 综述 • 上一篇

抗衰老酶蛋白SIRT6与炎症反应在慢性疾病中研究进展

王开（综述），于素平（审校）

第二军医大学附属公利医院口腔科，上海 200135

出版日期:2019-08-28 发布日期:2019-12-05
通讯作者: 于素平，教授. E-mail: yusuping4939@sohu.com
作者简介:王开（1983—），男，河北石家庄人，主治医师，硕士. E-mail: wang_kai123@aliyun.com
基金资助:
上海市浦东新区卫生和计划生育委员会优秀青年医学人才培养项目（PWRq2017-18）

Advances of Anti-aging Enzyme Protein SIRT6 and Inflammatory Response in Chronic Diseases

WANG Kai, YU Su-ping

Online:2019-08-28 Published:2019-12-05

摘要/Abstract

摘要： 抗衰老酶蛋白SIRT6是沉默配型信息调节蛋白家族中烟酰胺腺嘌呤二核苷酸（NAD+）依赖的一种组蛋白，具有抗衰老和调控炎症反应的作用。然而，SIRT6作为炎症反应关键调控蛋白，在调控全身系统慢性疾病及口腔颌骨相关炎症反应方面的具体机制尚不清楚。本文对SIRT6蛋白在慢性炎症反应发生的调控作用进行综述，为SIRT6蛋白是否能作为治疗口腔慢性疾病中炎症反应的靶向分子提供参考

关键词: 沉默配型信息调节蛋白SIRT6, 炎症反应, 慢性疾病

Abstract: Anti-aging enzyme SIRT6 is a histone dependent on nicotinamide adenine dinuclide (NAD+) in the silent match information regulatory protein family, which plays a role in anti-aging and regulating inflammatory response. However, as a key regulatory protein of inflammatory response, the specific mechanism of SIRT6 in regulating the inflammatory response of systemic system and chronic diseases on jaw bone remains unclear. This paper reviews recent literature about regulatory role of SIRT6 protein in chronic inflammation, so as to provide theoretical basis for whether SIRT6 protein can be used as a target for treatment of inflammatory reactions in chronic oral diseases.

Key words: Sirtuin 6, inflammatory response, chronic diseases

中图分类号:

R782

王开（综述），于素平（审校）. 抗衰老酶蛋白SIRT6与炎症反应在慢性疾病中研究进展[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2019.04.010.

WANG Kai, YU Su-ping. Advances of Anti-aging Enzyme Protein SIRT6 and Inflammatory Response in Chronic Diseases[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2019.04.010.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2019/V29/I4/235

参考文献

[1] Hall JA, Dominy JE, Lee Y, et al. The sirtuin family's role in aging and age-associated pathologies[J]. J Clin Invest, 2013, 123(3):973-979.

[2] Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice[J]. Nature, 2012, 483(7388):218-221.

[3] Baur JA, Ungvari Z, Minor RK, et al. Are sirtuins viable targets for improving healthspan and lifespan[J]? Nat Rev Drug Discov, 2012, 11(6):443-461.

[4] Luk T, Malam Z, Marshall J. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity[J]. J Leukoc Bio, 2008, 83(4): 804-816.

[5] 王晓虎，王佐林. 牙周炎大鼠上颌骨来源的BM-MSCs中破骨细胞相关因子的表达[J]. 口腔颌面外科杂志, 2017, 27(2):83-88.

[6] Pan PW, Feldman JL, Devries MK, et al. Structure and biochemical functions of SIRT6[J]. J Bio Chem, 2011, 286(16):14575-14587.

[7] Schuster S, Roessler C, Meleshin M, et al. A continuous sirtuin activity assay without any coupling to enzymatic or chemical reaction[J]. Sci Rep, 2016, 2016; 6: 22643-22657.

[8] Kugle S, Mostoslavsky R. Chromatin and beyond: the multitasking roles for SIRT6[J]. Trends Biochem Sci, 2014, 39(2):72-81.

[9] Kawahara TL, Michishita E, Adler AS, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span[J]. Cell,2009, 136(1):62-74.

[10] Zhong L, D'Urso A, Toiber D, et al. The histone deacetylase SIRT6 regulates glucose homeostasis via Hif1alpha[J]. Cell, 2010, 140(2):280-293.

[11] Sundaresan NR, Vasudevan P, Zhong L, et al. The sirtuin SIRT6 blocks IGF-Akt singaling and development of cardiac hypertrophy by targeting c-Jun[J]. Nat Med, 2012, 18(11):1643-1650.

[12] Polyakova O, Borman S, Grimley R, et al. Identification of novel interacting partners of sirtuin 6[J]. PLoS One, 2012, 7(12):e51555.

[13] Jiang H, Khan S, Wang Y, et al. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine[J]. Nature, 2013, 496(7443): 110-113.

[14] Xiao C, Wang RH, Lahusen TJ, et al. Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in SIRT6 mutant mice[J]. J Biol Chem, 2012, 287(50):41903-41913.

[15] Lee HS, Ka SO, Lee SM, et al. Overex-pression of sirtuin 6 suppresses in?覲ammatory responses and bone destruction in mice with collagen-induced arthritis[J]. Arthritis Rheum, 2013, 65(7):1776-1785.

[16] Maksin-Matveev A, Kan?覱 Y, Hochhauser E, et al. Sirtuin 6 protects the heart from hypoxic damage[J]. Exp Cell Res, 2015, 330(1):81-90.

[17] Hou KL, Lin SK, Chao LH, et al. Sirtuin 6 suppresses hypoxia-induced inflammatory response in human osteoblasts via inhibition of reactive oxygen species production and glycolysis-a therapeutic implication in inflammatory bone resorption[J]. Biofactors, 2017,43(2):170-180.

[18] 喻珊珊, 刘培庆. SIRT6在血管紧张素Ⅱ诱导心肌肥大中的表达研究[J]. 今日药学, 2013, 23(7):401-403.

[19] Zhang ZQ, Ren SC, Tan Y, et al． Epigenetic regulation of NKG2D ligands is involved in exacerbated atherosclerosis development in SIRT6 heterozygous mic[J]. Sci Rep, 2016, 6: 23912．

[20] 陈洋, 平键, 张晶, 等．淫羊藿苷提高 SIRT6 酶活性及抑制 NF-κB 炎症信号通路的实验研究[J]. 老年医学与保健, 2012, 18 (3):338-346.

[21] Neurath MF. Cytokines in inflammatory bowel disease[J]. Nat Rev Immunol, 2014, 14(5):329-342.

[22] Silberman DM, Ross K, Sande PH, et al. SIRT6 is required for normal retinal function[J]. PLoS One, 2014, 9(6):e98831.

[23] Gertler AA, Cohen HY. SIRT6, a protein with many faces[J]. Biogerontology, 2013, 14(6):629-639.

[24] Liu F, Bu HF, Geng H, et al. Sirtuin-6 preserves r-spondin-1 expression and increases resistance of intestinal epithelium to injury in mice[J]. Mol Med, 2017, 23: 272-284.

[25] Feng Y, Liang J, Zhai Y. Autophapy activated by SIRT6 regulates Aβ induced inflammatory response in RPEs[J]. Biochem Biophys Res commun, 2018, 496(4): 1148-1154.

[26] Hu X, Zhu S, Liu R. SIRT6 deficiency impairs corneal epithelial would healing[J]. Aging (Albany NY), 2018, 10(8):1932-1946.

[27] Kok SH, Hou KL, Hong CY, et al. Sirtuin6 Modulates Hypoxia-induced Apoptosis in Osteoblasts via Inhibition of Glycolysis: Implication for Pathogenesis of Periapical Lesions[J]. J Endodontics, 2015, 41(10):1631-1637.

[28] Liao X, Feng B, Zhang D, et al. The SIRT6 gene: Does it play a role in tooth de- velopment[J]? Plos one, 2017, 12(3):e0174255.

[29] Castaneda B, Simon Y, Jacques, et al. Bone resorption control of tooth eruption and root morphogenesis: Involvement of the receptor activator of NF-κB (RANK)[J]. J Cell Physiol, 2011, 226(1):74-85.

[30] 吴情, 周小康, 黄丹青等. 炎症因子白介素-6对骨细胞表达RANKL的影响[J].口腔颌面外科杂志, 2017, 27(1):8-12.

选择文件类型/文献管理软件名称

选择包含的内容

抗衰老酶蛋白SIRT6与炎症反应在慢性疾病中研究进展

Advances of Anti-aging Enzyme Protein SIRT6 and Inflammatory Response in Chronic Diseases

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	秦硕, 李冉, 李春梅, 李光辉, 孙明磊. 术前外周血炎症指标在腮腺恶性肿瘤中的诊断及预后价值分析[J]. 《口腔颌面外科杂志》, 2022, 32(6): 362-367.
[2]	王菲（综述），王佐林（审校）. 基质细胞蛋白CCN1/CYR61在骨再生中的作用[J]. 《口腔颌面外科杂志》, 2021, 31(5): 324-.
[3]	汪晓龙，曹顺顺，张鹏，舒传继. TLR4/MyD88信号通路在2型糖尿病并慢性牙周炎发病中的作用[J]. 《口腔颌面外科杂志》, 2019, 29(1): 39-43.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

抗衰老酶蛋白SIRT6与炎症反应在慢性疾病中研究进展

Advances of Anti-aging Enzyme Protein SIRT6 and Inflammatory Response in Chronic Diseases

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价